POLD1 and cancer: Although the mutation frequencies of POLD1 in ccRCC was not high compared with other cancers, and high tumor mutational burdens were not observed in ccRCC, the findings showed that both the CNV and SNV of the POLD1 gene were statistically significant with the clinical outcomes of the OS, PFS, and DSS in ccRCC patients.